Top US FDA Drug Policy Leader Leaving For White House Detail

 
• By Derrick Gingery

Grail Sipes, CDER deputy center director for regulatory policy, will move to the Executive Office of the President next month.

White House and FDA building 21
Elizabeth Jungman will take over Grail Sipes' advisory duties in the Center for Drug Evaluation and Research once she moves to the White House. • Source: Nielsen Hobbs; the Pink Sheet | Alamy images

More from US FDA

More from Agency Leadership